{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:35:23Z","timestamp":1791326123765,"version":"4.3.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2010,8,1]]},"DOI":"10.2174\/138161210792389225","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T00:36:20Z","timestamp":1283387780000},"page":"2666-2675","source":"Crossref","is-referenced-by-count":15,"title":["QSAR, Docking, and CoMFA Studies of GSK3 Inhibitors"],"prefix":"10.2174","volume":"16","author":[{"given":"Isela","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagamare","family":"Fall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Generosa","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/72325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T13:53:47Z","timestamp":1448027627000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1381-6128&volume=16&issue=24&spage=2666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,1]]},"references-count":0,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2010,8,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/138161210792389225","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,1]]}}}